DK

Dheeraj Kharwar

Active Director Director DIN 09311440
DIN 09311440 First appointment Sep 2021 Primary industry E-Commerce
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Dheeraj Kharwar

Data last updated:

Dheeraj Kharwar is a Director at Lorsun Pharma Private Limited (since 2021). The company operates in E-Commerce. Lorsun Pharma Private Limited reported revenue of ₹51,340 (FY 2025).

DIN 09311440
Primary Designation Director
Industry E-Commerce
First Appointment 08 Sep 2021
Oldest Company Age 5 yrs
Largest company Lorsun Pharma Private Limited · ₹51,340 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lorsun Pharma Private Limited U52599UP2021PTC151838
Director08 Sep 20212021₹51,340 (FY 2025)Active

Board colleagues of Dheeraj Kharwar

NameDINCompanyDesignation
Malti11244635Lorsun Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lorsun Pharma Private Limited
Premium access

Shareholding and investment profile for Dheeraj Kharwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dheeraj Kharwar

Dheeraj Kharwar currently holds 1 directorship: Lorsun Pharma Private Limited (Director, since 08 Sep 2021, revenue ₹51,340 (FY 2025)).

Dheeraj Kharwar was first appointed on 08 Sep 2021 as Director at Lorsun Pharma Private Limited.

The current boards of Dheeraj Kharwar's companies include Malti (Lorsun Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available